Loading…
Based on limited metadata, this warning letter was issued to Jacobs Pills, Inc. on May 31, 2018, for an unspecified product category classified as "Other." Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined. The issuing FDA office is also not identified in the available metadata. To understand the specific regulatory concerns and required corrective actions, the complete warning letter would need to be reviewed.